Home › Meningeal Carcinomatosis › New York
Meningeal Carcinomatosis clinical trials in New York
4 studies for Meningeal Carcinomatosis are looking for participants at sites in New York.
Cities in New York
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- NYU Langone Hospital - Brooklyn, Brooklyn
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06500481Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT06518057A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT05184816Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 23, 2026 · NCT06058988From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.